Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Exelixis Inc EXEL

Healthcare Biotechnology
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:EXEL)

Exelixis to Webcast Virtual 2025 Research & Development (R&D) Day on Wednesday, December 10, 2025

Business Wire 5 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL

ACCESS Newswire November 16, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL

ACCESS Newswire November 15, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL

ACCESS Newswire November 14, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL

ACCESS Newswire November 13, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL

ACCESS Newswire November 12, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL

ACCESS Newswire November 11, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL

ACCESS Newswire November 10, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL

ACCESS Newswire November 9, 2025
View More News ››

Opinion & Analysis (NDAQ:EXEL)

Exelixis Shares Climb 21% on Positive Phase 3 Advanced Kidney Cancer Study Results

Streetwise Reports April 21, 2020

Buy biotech when there's blood on the street: Pontifax's Ran Nussbaum

George S. Mack September 3, 2015

Stock picks including a coal play

J.W. Cotton November 4, 2009
View More Opinion ››

Bullboard Posts (NDAQ:EXEL)

fighting cancers

with a profitable operation valued at about $7 billion and a diverse portfolio of treatments. These include its Cabometyx drug for...
jw1trader - August 24, 2022

FYI (Seeking Alpha) Bret Jensen

I offer up three predictions that are highly probable in my opinion for Gilead in 2017 and its shareholders. 1. The dividend is hiked...
Carlos66 - January 11, 2017

RE:Anyone watching this?

I'm in let see what happen soon?? Mark
mark26 - August 16, 2014

Anyone watching this?

this is going to JUMP! $11 dollar target set by Piper Jaffray... get in this quick!!! http://www.fool.com/investing/general/2014/04/04...
stopstockingme - April 6, 2014

Venture Exchange News

http://www.tsx.com/en/news_events/news_releases/10-5-2007_TSXVenture-NewListingELE.html EXCELSIOR ENERGY LIMITED ("ELE"...
Oldmannorth - October 9, 2007

RE: Excelsior News - Sept 25

Bye Bye CNQ, hello TSX Venture. New symbol is ELE starts trading Tuesday October 9th.
britexile - October 9, 2007
View more Bullboard ››

Southern Energy Corp.

Southern Energy Corp.

Southern Energy Corp., together with its subsidiaries, operates as an oil and natural gas exploration and production company ...
View More »